“THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021013, Dec. 2020, doi: 10.4084/mjhid.2021.013.